Bernard De Prijck

650 total citations
24 papers, 230 citations indexed

About

Bernard De Prijck is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Bernard De Prijck has authored 24 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Genetics and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Bernard De Prijck's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Multiple Myeloma Research and Treatments (6 papers). Bernard De Prijck is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Multiple Myeloma Research and Treatments (6 papers). Bernard De Prijck collaborates with scholars based in Belgium, United States and France. Bernard De Prijck's co-authors include Yves Béguin, Laurence de Leval, Yuanping Zhou, Jacques Boniver, Ming‐Qing Du, Nancy L. Harris, Peter G. Isaacson, Frédéric Baron, Christophe Bonnet and Jo Caers and has published in prestigious journals such as Blood, The American Journal of Surgical Pathology and British Journal of Haematology.

In The Last Decade

Bernard De Prijck

21 papers receiving 228 citations

Peers

Bernard De Prijck
Bernard De Prijck
Citations per year, relative to Bernard De Prijck Bernard De Prijck (= 1×) peers Pierangelo Spedini

Countries citing papers authored by Bernard De Prijck

Since Specialization
Citations

This map shows the geographic impact of Bernard De Prijck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard De Prijck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard De Prijck more than expected).

Fields of papers citing papers by Bernard De Prijck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard De Prijck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard De Prijck. The network helps show where Bernard De Prijck may publish in the future.

Co-authorship network of co-authors of Bernard De Prijck

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard De Prijck. A scholar is included among the top collaborators of Bernard De Prijck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard De Prijck. Bernard De Prijck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marchiori, Silvano, François Cousin, I. Papadopoulos, et al.. (2024). Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma. EJNMMI Research. 14(1). 51–51. 3 indexed citations
2.
Letourneau, Audrey, Edoardo Missiaglia, Bernard De Prijck, et al.. (2021). Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. The American Journal of Surgical Pathology. 45(6). 773–786. 13 indexed citations
3.
Somja, Joan, et al.. (2021). Hereditary leiomyomatosis and acute lymphoblastic leukemia: A link through fumarate dyshydratase mutation?. Acta Clinica Belgica. 77(4). 778–781. 1 indexed citations
4.
Withofs, Nadia, Yves Béguin, François Cousin, et al.. (2019). Dual‐tracer PET/CT scan after injection of combined [18F]NaF and [18F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology. 37(2). 193–201. 5 indexed citations
5.
Muller, Joséphine, Céline Grégoire, Loïc Delens, et al.. (2018). [What is new in the management of multiple myeloma].. PubMed. 14(615). 1438–1442. 1 indexed citations
6.
Withofs, Nadia, François Cousin, Bernard De Prijck, et al.. (2017). A First Report on [18F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media & Molecular Imaging. 2017. 1–7. 4 indexed citations
7.
Withofs, Nadia, Paolo Simoni, Bernard De Prijck, et al.. (2016). Comparison of combined whole-body 18F-NAF and 18F-FDG PET/CT versus MRI for the detection of myeloma lesions. Open Repository and Bibliography (University of Liège). 57. 606–606. 1 indexed citations
8.
Bonnet, Christophe, Ann Janssens, Thomas Tousseyn, et al.. (2015). BHS Guidelines for the treatment of Burkitt’s lymphoma. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 6(2). 61–69. 5 indexed citations
9.
Hoof, Ambro van, Daan Dierickx, Virginie De Wilde, et al.. (2013). Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS).. Open Repository and Bibliography (University of Liège). 4(3). 90–101.
10.
Caers, Jo, Marie‐Christiane Vekemans, Karolien Beel, et al.. (2013). Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians. Annals of Medicine. 45(5-6). 413–422. 9 indexed citations
11.
Servais, Sophie, Bernard De Prijck, Corhay Jl, et al.. (2013). Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis.. PubMed. 67(5). 370–1. 3 indexed citations
12.
Malaise, Olivier, Sophie Servais, Daniela Betea, et al.. (2012). Panhypopituitarism and diabetus insipidus in a patient with primary central nervous system lymphoma. Open Repository and Bibliography (University of Liège).
13.
Bonnet, Christophe, et al.. (2012). [Diffuse large B cell lymphoma: management in 2012].. PubMed. 8(351). 1582–4, 1586. 1 indexed citations
14.
Bonnet, Christophe, et al.. (2011). [b]Lymphome[/b] du manteau : prise en charge 2011. Revue Médicale Suisse. 7(306). 1644–1649. 1 indexed citations
15.
Bron, Dominique, et al.. (2011). Use of alemtuzumab in B cell chronic lymphocytic leukaemia (CLL) : Belgian recommendations. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 2(2011). 64–69.
16.
Provencher, Sawyna, Céline Ferlay, Alain Devidas, et al.. (2010). Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series. Hematological Oncology. 29(1). 10–16. 17 indexed citations
17.
Servais, Sophie, et al.. (2010). Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B‐cell lymphoma. British Journal of Haematology. 150(3). 379–381. 19 indexed citations
18.
Béguin, Yves, Johan Maertens, Bernard De Prijck, et al.. (2008). Darbepoetin-Alfa and I.V. Iron Administration after Autologous Hematopoietic Stem Cell Transplantation: A Prospective Randomized Multicenter Trial. Blood. 112(11). 54–54. 13 indexed citations
19.
Leval, Laurence de, Bernard De Prijck, Yuanping Zhou, et al.. (2004). Distinct Clonal Origin in Two Cases of Hodgkin’s Lymphoma Variant of Richter’s Syndrome Associated With EBV Infection. The American Journal of Surgical Pathology. 28(5). 679–686. 63 indexed citations
20.
Prijck, Bernard De, Hilde Vranckx, Rolf Marschalek, et al.. (2001). Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5′ MLL sequences in chromosome 4. Leukemia. 15(4). 595–600. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026